Trial Profile
Prospective, multicentre, double-blind, randomized study investigating safety and efficacy of Armodafinil in patients with major depressive episodes associated with bipolar I disorder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Armodafinil (Primary)
- Indications Bipolar I disorders
- Focus Adverse reactions; Therapeutic Use
- 05 Feb 2016 New trial record